Skip to content

Explore EATRIS as         Login

EATRIS
  • About
        • About Eatris

        • Who we are
        • People
          • EATRIS Meets
        • Impact
        • Jobs
        • Governance
          • How to join EATRIS?
        • Legal
        • Spotlight Programme
        • Institutes
        • Countries
          • Bulgaria
          • Croatia
          • Czech Republic
          • Finland
          • France
          • Italy
          • Latvia
          • Luxembourg
          • Netherlands
          • Portugal
          • Slovakia
          • Slovenia
          • Spain
          • Sweden
          • Türkiye
  • Services
        • Services

        • Research Services
          • Industry–Academia collaborations
          • Support for funding applications
          • COVID-19
        • Innovation Services
          • Mentoring Services
          • Regulatory Services
          • Translational Feasibility Assessment
          • Health Technology Assessment
        • Education & Training
          • Transmed Academy
          • Education & Training News
          • Collaborating with Us
        • EATRIS Expert Centres
        • Self-Service Resources
          • Tracer Factory
          • Innovation Helpdesk
          • Innovation Management Toolbox
          • Multi-omics Toolbox (MOTBX)
          • Orphan Drug Development Guidebook (ODDG)
          • Patient Engagement Resource Centre
          • Regulatory Database (RIS)
  • Projects
        • Training
          • iRISE
          • EATRIS-CONNECT
          • ERDERA
        • Quality & Reproducibility
          • EATRIS Quality Initiative
          • EDITSCD
          • iRISE
          • OSCARS
          • STARDAST
        • COST ACTION
          • CINNAMON
          • HAPLO-iPS
          • INFLAMomx
        • Personalised Medicine
          • canSERV
          • Compass AI
          • EASI-OMICS
          • EATRIS-CONNECT
          • ECHoS 2
          • ERA4Health
          • ERDERA
          • EUCAIM
          • HEAL
          • iNDUCARE
          • iN-KEY
          • PRECISEU
          • RealiseD
          • REMEDi4ALL
          • SIMPATHIC
          • TRANSCAN-4
          • TRUSTroke
          • UMBRELLA
        • Research Infrastructure development
          • ACCESS2ACCESS
          • CANDLE
          • canSERV
          • EATRIS-CONNECT
          • ERIC Forum 2
          • ISIDORe II
          • RITIFI
          • SIRENE
          • Spotlight Programme
          • TransBioNet
        • Industry collaborations
          • ERA4Health
          • ERDERA
          • GSK Hub
          • RealiseD
          • REMEDi4ALL
        • Long-term partnerships
          • Translation Together
          • EATRIS Quality Initiative
          • EU-AMRI
          • NewFound
          • Patient engagement
        • Cross-Research Infrastructure Collaboration
        • Archive of past projects
  • Platforms
        • Platforms

        • ATMP
        • Small Molecules
        • Vaccines, Inflammation and Immune Monitoring
        • Biomarkers
        • Imaging & Tracing
  • News
  • Events
  • Resources
        • 2025 EATRIS Annual Report
          • Annual Report Archive
        • Gender Equality in EATRIS
        • Strategic Plan 2023-2026
          • Strategic Plan 2019-2022
        • Sustainability Plan 2024-2030
        • Advocacy Efforts
        • Publications Citing EATRIS
          • How to acknowledge EATRIS
        • FUNDING OPPORTUNITIES FOR MEMBERS
        • Brand Centre
        • Glossary, abbreviations and acronyms
        • Leaflets
          • EATRIS One-pager
          • Platform leaflets
          • Support for Funding Applications leaflet
          • Technology Leaflets
  • Contact
Countries
All Bulgaria Croatia Czech Republic Finland France Italy Latvia Luxembourg Netherlands Portugal Slovakia Slovenia Spain Sweden Türkiye

Countries

All Bulgaria Croatia Czech Republic Finland France Italy Latvia Luxembourg Netherlands Portugal Slovakia Slovenia Spain Sweden Türkiye
23 June 2026
 

EATRIS-CONNECT AGM 2026 Concludes with Public Session on Patient Engagement in the Digital Age

22 June 2026
 

EATRIS Welcomes Türkiye as an Observer

17 June 2026
 

EATRIS 2025 Annual Report Now Available

11 June 2026
 

Producing heart cells from iPSCs faster and more cost-effectively

10 June 2026
 

2026 EATRIS Node Rewards Announced

9 June 2026
 

EATRIS Spotlight Programme Continues in Prague with Czech Republic Handing Over to Italy

29 May 2026
 

iDR26 Brings Together the Drug Repurposing Community in Brussels

17 April 2026
 

SAGANET awards Rosan Kreeftmeijer-Vegter Best New Serious Game Designer for REPURPOLIS

15 April 2026
 

Patient Engagement Resource Centre Featured in New European Parliament Think Tank Report

30 March 2026
 

Call for Demonstrators – (Future) Digital Biomarkers

23 March 2026
 

EATRIS-CONNECT Policy Brief – Navigating Europe’s Digital Health Regulations for PerMed

23 February 2026
 

Digital Symposium on New Approach Methodologies Brings together the EATRIS Small Molecules Community

13 February 2026
 

ECHoS Consortium calls for a bold move to accelerate Europe’s fight against Cancer

9 February 2026
 

Health~Holland awards €3.2 million to BRAINS for public-private partnerships in brain research

27 January 2026
 

Digital technologies improving quality of life in paediatric oncology patients at EATRIS-CONNECT partner institute

17 December 2025
 

THOR Project Wins the VTSO-XarSMART Health Innovation Award

11 December 2025
 

EATRIS Spotlight Programme Enters New Chapter with Portugal Handing Over to Czech Republic

9 December 2025
 

Newly updated EATRIS Cell and Gene Therapy (ATMP) Development E-learning Course for Rare Disease Professionals.

Posts navigation

Older posts

Sign up for news and updates

By signing up, you agree to our Privacy Policy

EATRIS ERIC logo

EATRIS ERIC
De Boelelaan 1117
1081 HV Amsterdam
The Netherlands

T +31 20 444 2254
E info@eatris.eu

WITH THANKS TO OUR FUNDERS AND PARTNERS




© Copyright EATRIS ERIC | Privacy Policy | EATRIS ERIC Statutes | EATRIS ERIC was established by Commission Implementing Decision 2013/640/EU of 7 November 2013